12:00 AM
Oct 02, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Breast cancer; prostate cancer Insulin-like growth factor-1 receptor (IGF1R; CD221); dishevelled segment polarity protein 3 (DVL3) Studies in vitro and in human...

Read the full 242 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >